Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-02-02Clinical Trial Update: Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA) [Phase 3]
Phase III open-label comparative study of the rheumatoid arthritis drug MRA completed.
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Assessment of Body Image in Patients With Rheumatoid Arthritis
A completed clinical trial examining body image concerns among rheumatoid arthritis patients.
-
FDA approval · 2009-01-14FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for etodolac by Taro Pharmaceuticals U.S.A., Inc. under the ANDA program.
-
FDA approval · 2009-01-14FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for etodolac filed by Taro Pharmaceuticals U.S.A., Inc., authorizing changes to labeling and/or manu…
-
CLINICAL_TRIALS trial_result · 2008-12-23Clinical Trial Update: Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT) [Phase 4]
A Phase 4 trial (SWEFOT) evaluated adding an anti-TNF agent to methotrexate versus adding conventional DMARDs to methotrexate in patients wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-12-15Clinical Trial Update: Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA) [NA]
Completed a drug-drug interaction study of a mineralocorticoid receptor antagonist (MRA) in a patient with rheumatoid arthritis, sponsored b…
-
CLINICAL_TRIALS trial_result · 2008-12-15Clinical Trial Update: Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment [NA]
A completed clinical pharmacology study evaluating MRA in patients with rheumatoid arthritis and renal impairment.
-
CLINICAL_TRIALS trial_result · 2008-12-05Clinical Trial Update: Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes [Phase 4]
Phase 4 clinical trial update compares rheumatoid arthritis patients' preference for Enbrel auto-injector versus Enbrel pre-filled syringes.…
-
CLINICAL_TRIALS trial_result · 2008-12-05Clinical Trial Update: REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations
Clinical trial update for the REKinDLE registry, comparing Enbrel (etanercept) and Kineret (anakinra) in rheumatoid arthritis; the study sta…
-
CLINICAL_TRIALS research · 2008-12-05Clinical Trial Update: Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA) [NA]
The PETRA trial, investigating positron emission tomography in rheumatoid arthritis patients treated with adalimumab, has completed.
-
FDA approval · 2008-10-29FDA Approved: NAPROXEN — Supplemental Application (Granules India Ltd)
FDA approved a supplemental application from Granules India Ltd for Naproxen (Naproxen sodium) granules. This adds a granulated dosage form …
-
CLINICAL_TRIALS trial_result · 2008-10-17Clinical Trial Update: Effects of a Multi-Faceted Psychiatric Intervention Targeted at the Complex Medically Ill: a Randomized Controlled Trial [Phase 4]
Phase 4 randomized trial evaluating a multi-faceted psychiatric intervention in medically complex patients has completed. The study included…
-
CLINICAL_TRIALS trial_result · 2008-10-13Clinical Trial Update: A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis
A completed clinical trial update evaluating inflammatory markers in patients with Rheumatoid arthritis and Osteoarthritis, sponsored by Gla…
-
FDA approval · 2008-09-24FDA Approved: NABUMETONE — Original Application (ScieGen Pharmaceuticals Inc)
FDA approves ScieGen Pharmaceuticals Inc's Nabumetone as a generic product under an Original Application (ANDA), marking its regulatory appr…
-
CLINICAL_TRIALS research · 2008-09-08Clinical Trial Update: Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan
Clinical trial comparing health-related quality of life and disease-related costs among ankylosing spondylitis, rheumatoid arthritis, and sy…
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Objective Study in Rheumatoid Arthritis [Phase 4]
Sanofi-sponsored Phase 4 trial in rheumatoid arthritis has completed; the update does not provide trial results.
-
CLINICAL_TRIALS research · 2008-08-25Clinical Trial Update: Treatment of Rheumatoid Arthritis With Marine and Botanical Oils [Phase 3]
An ongoing Phase 3 trial evaluating marine and botanical oils for rheumatoid arthritis, with current status not disclosed.
-
CLINICAL_TRIALS trial_result · 2008-08-06Clinical Trial Update: Effects of Pulsed Magnetic Pads on Rheumatoid Arthritis Symptoms in Postmenopausal Women [Phase 2]
A Phase 2 clinical trial evaluating the effect of pulsed magnetic pads on rheumatoid arthritis symptoms in postmenopausal women has complete…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis [Phase 2]
Phase 2 study of Fontolizumab in active rheumatoid arthritis was terminated.
-
CLINICAL_TRIALS trial_result · 2008-08-04Clinical Trial Update: A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis [Phase 3]
A Phase 3 study evaluating the safety and efficacy of adding adalimumab to inadequate standard anti-rheumatic therapy in patients with activ…
-
FDA approval · 2008-07-31FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for Tolmetin Sodium from Atland Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2008-07-29Clinical Trial Update: A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial evaluating intravenously administered Paxceed for rheumatoid arthritis has completed.
-
FDA approval · 2008-07-25FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
The FDA has approved a supplemental application for naproxen filed by Zameer Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2008-07-24Clinical Trial Update: A Prevalence Study of Chronic Widespread Pain (CWP) Among Patients With Rheumatoid Arthritis (RA) and Control Population in Tallinn and Harjumaa County
A clinical trial update describing a prevalence study of chronic widespread pain among patients with rheumatoid arthritis and a control popu…
-
CLINICAL_TRIALS trial_result · 2008-07-22Clinical Trial Update: Ramipril in Rheumatoid Arthritis [Phase 2, Phase 3]
A completed clinical trial evaluating ramipril for rheumatoid arthritis, spanning Phase 2 and Phase 3, conducted by the University of Zurich…